At $73 per share Procter and Gamble is trading well below its intrinsic value calculated as of 06/22/2007. The projected price target of $84.25 is a blend of a Discounted Cash Flow valuation and a comparable firm analysis. A DCF valuation with conservative growth and a Cost of Capital of 6.2% yields a share price of $90.09 (See attached Spreadsheet). The comparable analysis gives an Exit Multiple of roughly 18x last year EBITDA which results in a valuation of $78.40 per share. Please note: Recent turbulence in the credit markets may cause some variance to the intrinsic value but does not change this analysis. Macroeconomic risks are not a strong headwind for Procter and Gamble.
Procter and Gamble has tremendous exposure to fast growing markets such as India and China and this exposure will further add to sales growth in the near future. The firm is effective at leveraging its global presence to increase economies of scale and promote cost synergies. Additionally, expect to see synergies from the acquisition of Gillette and Wella translate into greater earnings and add to cash flow. The company has also been increasing its dividend per share every year which it is able to do with its substantial cash position. The generous amount of Free Cash flow also allows Procter and Gamble to make strategic acquisitions which further enhance its competitive position and allows it to maintain its competitive advantage over rivals.
With solid corporate governance, strong global brand, aggressive growth strategies and sound management with long term vision, Procter and Gamble is a firm poised to maintain its leadership in the consumer staples sector and continue to be hugely profitable in the years to come. This is a company that surely has a presence in our households and deserves a position in our portfolio.
--Gaurav 13:35, December 17, 2007 (PST)
€